Literature DB >> 16996325

Determination of eflornithine enantiomers in plasma, by solid-phase extraction and liquid chromatography with evaporative light-scattering detection.

M Malm1, Y Bergqvist.   

Abstract

A bioanalytical method for determination of eflornithine (DFMO) in 1000 microL human plasma has been developed and validated. DFMO and the internal standard (IS) were analysed by liquid chromatography with evaporative light-scattering detection (ELSD). Separation was performed on a Chirobiotic TAG (250 mm x 4.6 mm) column with ethanol (99.5%):0.01 mol/L acetic acid-triethylamine buffer at the rate of 25:75% (v/v) with flow rate of 1.0 mL/min. For d-DFMO in plasma the inter-assay precision was 6.5% at 75 micromol/L, 6.6% at 375 micromol/L and 5.8% at 750 micromol/L. For l-DFMO in plasma the inter-assay precision was 10.4% at 75 micromol/L, 6.5% at 375 micromol/L and 5.0% at 750 micromol/L. The lower limit of quantification (LLOQ) was determined to 25 micromol/L where the precision was 4.3% and 5.7%, respectively.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16996325     DOI: 10.1016/j.jchromb.2006.08.030

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  3 in total

1.  Enantioselective and nonlinear intestinal absorption of eflornithine in the rat.

Authors:  R Jansson; M Malm; C Roth; M Ashton
Journal:  Antimicrob Agents Chemother       Date:  2008-06-02       Impact factor: 5.191

2.  Population pharmacokinetic modeling and deconvolution of enantioselective absorption of eflornithine in the rat.

Authors:  Carl-Christer Johansson; Peter Gennemark; Per Artursson; Angela Äbelö; Michael Ashton; Rasmus Jansson-Löfmark
Journal:  J Pharmacokinet Pharmacodyn       Date:  2013-01-10       Impact factor: 2.745

3.  Application of Hantzsch reaction for sensitive determination of eflornithine in cream, plasma and urine samples.

Authors:  Albandary Almahri; Mohamed A Abdel-Lateef
Journal:  R Soc Open Sci       Date:  2021-05-12       Impact factor: 2.963

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.